Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma
Status:
Completed
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
This study is designed to assess the effectiveness of the combination of Panobinostat plus
Bortezomib and Dexamethasone in patients with relapsed and bortezomib refractory Multiple
Myeloma.